Profile

Hi we’re Vital Meat!

Vital Meat acquired by Gourmey, the company builds on deep expertise in cell cultivation, bioprocessing, and food science

Hi we’re SPRIN-D!

SPRIN-D is Germany’s federal agency funding high-risk, high-reward synthetic biology projects focused on sustainable biomanufacturing and circular bioeconomy solutions. It supports innovation through grants and challenges that accelerate the development of breakthrough bioprocessing technologies.

Hi we’re LongeVC!

LongeVC is a venture capital firm focused on advancing an ageless future by investing in early-stage biotech and longevity companies developing breakthrough therapeutics and scalable bio-based material solutions.

Hi we’re IQ Capital!

Hi we’re Corn Lab!

The Corn Lab develops next-generation genome editing and regulation technologies to study DNA repair, hematopoietic stem cell maintenance, and organelle turnover, combining fundamental research with translational projects to advance biological understanding and potential therapies for human genetic diseases.

Hi we’re Anemocyte!

Anemocyte is a Biotech Manufacturing Organization (“BMO”) based in Italy, offering comprehensive development and manufacturing services and providing innovative solutions and products from R&D to GMP. Specialized in the research, development, and production of pDNA and mRNA, Anemocyte brings over 25 years of expertise in innovative therapies and related starting materials.

Hi we’re Genenta!

Genenta is a clinical-stage immuno-oncology company developing Temferon™, a first-in-class hematopoietic stem cell therapy designed to deliver immune-therapeutic payloads within the tumor microenvironment through bone marrow–derived myeloid cells for a durable and targeted anti-tumor response.

Hi we’re 2ndF!

2ndF, a Venture Capital and Private Equity firm, invested in AI-powered cell manufacturing platform that leverages predictive modeling and high-throughput control to engineer human cells and organoids